- Bedoelde u
- geeft roberfroid
Zoekresultaten - 5 results
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
Maes; Alexander Schauwvlieghe; Laurens Liesenborghs; Ann Belmans; Peter Verhamme; Geert Meyfroidt; DAWn-plasma investigators Source: Eur Respir J (2021) Abstract: BACKGROUND: Several randomised clinical ...
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.
Verbeke, Geert; Vlieghe, Erika; Jean Cyr Yombi; Laurens Liesenborghs; Peter Verhamme; Geert Meyfroidt Source: Trials, Volume 21, Issue 1 (2020) Health Topics: Health and disease monitoring Surveillance de ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Verbeke, Geert; Vlieghe, Erika; Jean Cyr Yombi; Laurens Liesenborghs; Peter Verhamme; Geert Meyfroidt Source: Trials, Volume 21, Issue 1 (2020) Keywords: Adult Antibodies, Viral Belgium Combined Modality ...
The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
Geert Meyfroidt; Dominique Van Beckhoven Source: The Lancet Regional Health- Europe (2021) Health Topics: COVID-19 Manuscript versions: DOI: https://doi.org/10.1016/j.lanepe.2020.100019 File: ...
Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients.
Publication Type: Peer reviewed scientific article Authors: Faes, Christel; Steven Abrams; Dominique Van Beckhoven; Geert Meyfroidt; Vlieghe, Erika; Hens, Niel; Belgian Collaborative Group on ...